Early studies suggest these medications may: Improve insulin sensitivity , potentially reducing hyperinsulinaemia and its downstream effects Promote weight loss , which can help restore ovulatory function in overweight women with PCOS [3] Potentially affect androgen levels through metabolic improvements Possibly support menstrual regularity through metabolic improvements However, it is crucial to note that there is no official licence for Ozempic in the treatment of PCOS or ovarian cysts in the UK
Sanjay Bharti, MD , offers GLP-1 therapy for medical weight loss in Fairmont, WV
Testing for Diabetes and Prediabetes: A1C | Diabetes | CDC Chen, Y., Zhou, X., Bullard, K
Weight regain is common when stopping semaglutide, with clinical studies showing patients often regain a significant portion of lost weight within one year of discontinuation